At our recent annual Group Benefit seminar, we hosted breakout sessions with a number of groups. Seeking insights, our topic of discussion was drug plan sustainability.
With more than 80 people in attendance, we were able to gather a good deal of information about the current state of our attendees’ drug plans, the challenges they’re facing and where they felt there was opportunity to spend more effectively. We’ve compiled this information into a short article, which we are pleased to share with you.
We hope you find it to be interesting and useful!